255 tracked 13F filers disclose a position in DNLI as of the latest SEC 13F filings, a combined $2.8B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $250.3M | 13.0M | ▲+2.5% Added · +319K sh | Q1 2026 | |
| 2 | BAILLIE GIFFORD & CO | $231.7M | 12.1M | ▼−2.0% Reduced · −244K sh | Q1 2026 | |
| 3 | T. Rowe Price Investment Management, Inc. | Withheld | 8.5M | ▲+17% Added · +1.3M sh | Q1 2026 | |
| 4 | STATE STREET CORP | $181.3M | 7.0M | ▲+12% Added · +777K sh | Q2 2026 | |
| 5 | Temasek Holdings (Private) Ltd | $180.4M | 7.0M | —Held | Q2 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $118.0M | 6.1M | →First observed position No prior filed position | Q1 2026 | |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $117.5M | 6.1M | →First observed position No prior filed position | Q1 2026 | |
| 8 | NORGES BANK | $84.5M | 5.1M | ▲+30% Added · +1.2M sh | Q4 2025 | |
| 9 | FMR LLC | $87.8M | 4.6M | ▼−25% Reduced · −1.5M sh | Q1 2026 | |
| 10 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $85.1M | 4.4M | ▼−11% Reduced · −551K sh | Q1 2026 | |
| 11 | GOLDMAN SACHS GROUP INC | $84.6M | 4.4M | ▲+15% Added · +571K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $102.2M | 4.0M | ▲+6.6% Added · +246K sh | Q2 2026 | |
| 13 | BAKER BROS. ADVISORS LP | $71.6M | 3.7M | —Held | Q1 2026 | |
| 14 | Holocene Advisors, LP | $61.4M | 3.2M | ▲+1.4% Added · +43K sh | Q1 2026 | |
| 15 | ALLIANCEBERNSTEIN L.P. | $47.8M | 2.9M | ▼−19% Reduced · −664K sh | Q1 2026 | |
| 16 | DIMENSIONAL FUND ADVISORS LP | $51.7M | 2.7M | ▲+13% Added · +318K sh | Q1 2026 | |
| 17 | UBS Group AG | $49.4M | 2.6M | ▲+6.9% Added · +167K sh | Q1 2026 | |
| 18 | Pictet Asset Management Holding SA | $48.4M | 2.6M | ▲+93% Added · +1.2M sh | Q1 2026 | |
| 19 | PRICE T ROWE ASSOCIATES INC /MD/ | $47.3M | 2.5M | ▼−37% Reduced · −1.5M sh | Q1 2026 | |
| 20 | Fisher Asset Management, LLC | $46.8M | 2.4M | ▼−5.9% Reduced · −153K sh | Q1 2026 | |
| 21 | Alyeska Investment Group, L.P. | $37.3M | 1.9M | ▲+126% Added · +1.1M sh | Q1 2026 | |
| 22 | Crestline Management, L.P. | $49.1M | 1.9M | ▼−14% Reduced · −300K sh | Q2 2026 | |
| 23 | ADAR1 Capital Management, LLC | $35.9M | 1.9M | ▲36× Added · +1.8M sh | Q1 2026 | |
| 24 | Aberdeen Group plc | $35.6M | 1.9M | ▼−8.8% Reduced · −179K sh | Q1 2026 | |
| 25 | Casdin Capital, LLC | $35.3M | 1.8M | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in DNLI and 25 added to an existing one, while 21 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 133 funds | $177.4B |
| NVIDIA CORPNVDA | 131 funds | $354.1B |
| ALPHABET INC-CL AGOOGL | 131 funds | $144.9B |
| META PLATFORMS INC-CLASS AMETA | 130 funds | $101.5B |
| APPLE INCAAPL | 129 funds | $261.8B |
| MICROSOFT CORPMSFT | 129 funds | $231.3B |
| ELI LILLY & COLLY | 128 funds | $70.2B |
| MERCK & CO. INC.MRK | 126 funds | $26.3B |
| UNITEDHEALTH GROUP INCUNH | 126 funds | $24.5B |
| BROADCOM INCAVGO | 123 funds | $134.9B |
| ADVANCED MICRO DEVICESAMD | 122 funds | $31.2B |
| TESLA INCTSLA | 121 funds | $62.5B |
Ranked by how many of DNLI's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | Schuth Alexander O. | COFO and Secretary | Sell (S) | 3K | $72K |
| Jan 6, 2026 | Watts Ryan J. | President and CEO, Director | Sell (S) | 35K | $581K |
| Jan 6, 2026 | Schuth Alexander O. | COFO and Secretary | Sell (S) | 17K | $284K |
| Aug 13, 2025 | Ho Carole | Chief Medical Officer | Sell (S) | 806 | $12K |
| Aug 12, 2025 | Ho Carole | Chief Medical Officer | Sell (S) | 3K | $40K |
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | Sell (S) | 3K | $40K |
| Jul 9, 2025 | Watts Ryan J. | President and CEO, Director | Sell (S) | 495K | $7.4M |
| Jan 7, 2025 | Krognes Steve E. | Director | Sell (S) | 3K | $69K |
| Jan 7, 2025 | Watts Ryan J. | President and CEO, Director | Sell (S) | 8K | $159K |
| Jan 7, 2025 | Schuth Alexander O. | COFO and Secretary | Sell (S) | 3K | $60K |
| Jan 7, 2025 | Ho Carole | Chief Medical Officer | Sell (S) | 3K | $60K |
| Jan 6, 2025 | Watts Ryan J. | President and CEO, Director | Sell (S) | 29K | $592K |
Connected entities for DNLI
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DNLI/capital-change-brief"
Use Arkolith's capital_change_brief for DNLI. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DNLI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.